Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGD
Status:
Recruiting
Trial end date:
2023-07-18
Target enrollment:
Participant gender:
Summary
This is a phase II exploratory study conducted to evaluate the safety and efficacy of the
combination of Ibuprofen, G-CSF and Plerixafor as stem cell mobilization regimen in patients
affected by X-CGD.